ZGNX CLASS ACTION REMINDER: Hagens Berman Reminds Zogenix (ZGNX) Investors of Class Action of Upcoming Deadline

05/23/2019

San Francisco - Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, reminds investors in Zogenix, Inc. (NASDAQ: ZGNX) of the upcoming June 11, 2019 lead plaintiff movant deadline in the securities class action, Lake v. Zogenix, Inc. et al., No. 3:19-cv-01975, pending in the U.S. District Court for the Northern District of California.

If you purchased or otherwise acquired Zogenix securities between February 6, 2019 and April 8, 2019 (the “Class Period”) and suffered substantial losses (in excess of $50,000), you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.

If you wish to serve as a lead plaintiff in this class action, you must move the Court no later than June 11, 2019 (the “Lead Plaintiff deadline”).  Contact Hagens Berman immediately for more information about the case and being a lead plaintiff:

https://www.hbsslaw.com/cases/ZGNX

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

ZGNX@hbsslaw.com.

According to the complaint, Defendants misled investors about Zogenix’s New Drug Application (“NDA”) for FINTEPLA® by misstating and/or concealing information that the NDA (1) contained inadequate non-clinical data and an incorrect version of a clinical dataset, and (2) consequently the NDA was unlikely to gain approval by the U.S. Food & Drug Administration (“FDA”).

“We’re focused on investors’ losses, whether Defendants knew that the NDA they submitted on February 5 was not sufficiently complete to permit the FDA to conduct a substantive review, and the extent to which investors may have been misled,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Zogenix should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email ZGNX@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a nationwide law firm that represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000


Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.

Back to all cases

Contact:

Please fill out the form below and we will get back to you as soon as we can.
 
Full Name *
Phone *
Email *
Shares Purchased During the Class Period *
Estimated Total Losses *
*Required field
Please list the date, quantity and share price of your purchases/sales during the Class Period so that we can calculate your losses. *
Upload your trade information. *
*
*
*
*
 

Case videos

Case Gallery

Case Timeline

04/15/19: Investigation